BioTheryX
PrivateLast Round
Corporate Funding
Apr 5, 2023
Total Funding Raised
$131.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
BioTheryX operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was a Series E round in May 2021.
BioTheryX is a biopharmaceutical company that develops innovative treatments for life-threatening diseases through targeted protein degradation and molecular glues.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioTheryX Comparables
Compare BioTheryX with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Plexium | 87% | |
| Cullgen | 83% | |
| Neomorph | 83% |
For institutional investors. Book with your work email.
BioTheryX Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Apr 5, 2023 | ||||
| Series E | May 20, 2021 | ||||
| Series D | Jul 28, 2020 | ||||
| Series A | Nov 30, 2010 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
BioTheryX Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Surveyor Capital | Series E |
| Janus Henderson Group | Series E |
| Wedbush Healthcare Partners | Series E |
| Farallon Capital Management | Series E |
| Deep Track Capital | Series E |
| Avidity Partners | Series E |
| Irving Investors | Series E |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 81% MoM.
- Jul 24, 2026
Monthly visitors grew 86% MoM, reaching 2.2K.
For institutional investors. Book with your work email.
BioTheryX Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BioTheryX's valuation, stock price, and market status.
Is BioTheryX a public or private company?
BioTheryX is a private company.
What is the current stock price of BioTheryX?
BioTheryX is a private company, so its shares have no public market price. Caplight tracks BioTheryX's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BioTheryX worth (valuation)?
Valuation information for BioTheryX is not publicly available.
Can I buy BioTheryX stock?
BioTheryX shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BioTheryX's last funding round?
BioTheryX's most recent funding round was Corporate Funding on April 5, 2023.
Who are the main investors in BioTheryX?
Key investors in BioTheryX include Farallon Capital Management, BDT & MSD Partners, Blood Cancer United.
Will BioTheryX IPO soon?
No public IPO plans have been announced for BioTheryX.
How can I track BioTheryX secondary market activity?
Caplight tracks bids, offers, and trades in BioTheryX's shares on secondary markets.